(1/6)As #IndiaCOVIDcrisis grows, more people from my closer circle are getting infected with #COVID. The one COMMON QUESTION that I get asked is “How can I get #Remdesivir?” And my only response is, “Don’t waste your time searching Remdesivir!”
And here is why...👇
And here is why...👇
(2/6)The @WHO living guideline on Therapeutics and COVID19 clearly outlines recommendations (with evidence). Here is a quick snapshot! 
(3/6)The below image is a Network map from the living network meta-analysis informing this guideline. Within the map, the size of the nodes (blue
circles) correlates with the number of patients randomized to that intervention across all included trials
circles) correlates with the number of patients randomized to that intervention across all included trials
(4/6)Link to WHO Living Guideline 👉 who.int/publications/i…
(5/6) Another very useful resource for evidence-based guidelines is the COVID-19 Guidelines Dashboard by @OpenCritCareOrg
Link 👉opencriticalcare.org/covid-dashboar…
Link 👉opencriticalcare.org/covid-dashboar…
(6/6) In this day and age, as much as it is easy to get misinformed, it is also easy to get #evidencebased information. Trust #EvidenceNotOpinions!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
